Nakayama N
No ORCID on file
· 7 papers in corpus
· active 2012-2025
Study types
- article 3
- other 2
Condition tags
- endometriosis 3
- adenomyosis 2
- dysmenorrhea 1
Top journals
Frequent coauthors
- Nakayama K 5
- Naomi Nakayama 5
- Ishikawa M 5
- Kobayashi H 4
- Kentaro Nakayama 4
- Miyazaki K 4
- Iida K 4
- Ishibashi T 4
- Katagiri A 4
- Masako Ishikawa 3
article
2025
NAC1, a transcription regulator protein associated with cancer, is highly expressed in several tumor types, including ovarian cancer. However, it remains unclear how NAC1 is involved in carcinogenesis. Our previous studies demonstrated that…
other
2025
Nucleus accumbens-associated protein 1 (NAC1), a cancer-related transcriptional regulator, is overexpressed in several malignancies, including ovarian cancer. However, its role in ovarian carcinogenesis remains unclear. We aimed to investig…
article
2013
We report anesthetic management of a 38-year-old woman with pulmonary thromboembolism for total hysterectomy. She had been taking oral contraceptives for adenomyosis of the uterus. She had thrombi in the arteries from pulmonary trunk to bil…
2013
In this study, we examined the clinical significance of KRAS and MAPK1 amplification and assessed whether these amplified genes were potential therapeutic targets in type II ovarian carcinoma. Using fluorescence in situ hybridization, immun…
article
2013
AIM: We aimed to evaluate the efficacy of microwave endometrial ablation at a frequency of 2.45 GHz in women with menorrhagia. This method has been attracting attention as an alternative to hysterectomy in the treatment of functional and or…
2012
BackgroundThis study examined the clinical significance of NAC1 and the expression level of its potential downstream target fatty acid synthase (FASN) in ovarian clear cell carcinomas (OCCCs), and evaluated the NAC1/FASN pathway as a potent…
other
2012
Recently, the ARID1A gene has been identified as a novel tumor suppressor in ovarian clear cell carcinoma. The prognostic significance of the loss of ARID1A expression is not known. The current study was designed to evaluate whether ARID1A …